Stocktoria
ALNYLAM PHARMACEUTICALS, INC. ALNY
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2004-05-28
ALNYLAM PHARMACEUTICALS, INC. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| BlackRock Finance, Inc. | 9,547,663 | $2.3B |
| TWO SIGMA INVESTMENTS, LP | 1,992,577 | $659.3M |
| DODGE & COX | 1,929,253 | $638.3M |
| D. E. Shaw & Co., Inc. | 1,474,362 | $487.8M |
| AQR CAPITAL MANAGEMENT LLC | 913,104 | $297.9M |
| MILLENNIUM MANAGEMENT LLC | 493,087 | $163.1M |
| CITADEL ADVISORS LLC | 111,215 | $36.8M |
| Bridgewater Associates, LP | 106,592 | $35.3M |
Source: SEC EDGAR filings · CIK 0001178670 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.